Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $70.487 million which beat the analyst consensus estimate of $69.059 million by 2.07 percent. This is a 12.68 percent decrease over sales of $80.721 million the same period last year.